• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】18672

【品名】azepane

【CA登记号】111-49-9

【 分 子 式 】C6H13N

【 分 子 量 】99.17596

【元素组成】C 72.66% H 13.21% N 14.12%

与该中间体有关的原料药合成路线共 10 条

合成路线1

该中间体在本合成路线中的序号:(V)

Alkylation of 5-hydroxyisoquinoline (I) with bromide (II) in DMF at 80 C afforded isoquinolinium salt (III). This was reduced to tetrahydroisoquinoline (IV) by catalytic hydrogenation in the presence of Pd/C. Finally, Mannich reaction with formaldehyde and perhydroazepine (V) in THF-water at r.t. provided the target compound.

1 Yuen, P.; Schelkun, R.M.; Szoke, B.; Tarczy-Hornoch K.; Synthesis and structure-activity relationship of substituted 1,2,3,4-tetrahydroisoquinolines as N-type calcium channel blockers. Bioorg Med Chem Lett 1998, 8, 18, 2415.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18668 5-isoquinolinol 2439-04-5 C9H7NO 详情 详情
(II) 18669 1-(4-bromo-1-phenylbutyl)benzene C16H17Br 详情 详情
(III) 18670 2-(4,4-diphenylbutyl)-5-hydroxyisoquinolinium bromide C25H24BrNO 详情 详情
(IV) 18671 2-(4,4-diphenylbutyl)-1,2,3,4-tetrahydro-5-isoquinolinol C25H27NO 详情 详情
(V) 18672 azepane 111-49-9 C6H13N 详情 详情

合成路线2

该中间体在本合成路线中的序号:(V)

The esterification of 4,4-bis(4-hydroxyphenyl)pentanoic acid (I) with diazomethane in ethyl ether/methanol gives the methyl ester (II), which is treated with phenylmagnesium bromide in THF to yield 4,4-bis(4-hydroxyphenyl)-1,1-diphenyl-1-pentanol (III). The reduction of (III) with H2 over Pd/C in methanol affords 4,4-bis(4-hydroxyphenyl)-1,1-diphenylpentane (IV), which is finally condensed with azepane (V) and formaldehyde in hot ethanol/water.

1 Yuen, P.-w.; Malone, T.C.; Tarczy-Hornoch, K.; Rock, D.M.; Szoke, B.; Stoehr, S.; Schelkun, R.M.; Synthesis and biological activity of substituted bis-(4-hydroxyphenyl)methanes as N-type calcium channel blockers. Bioorg Med Chem Lett 1999, 9, 16, 2447.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 17616 bromo(phenyl)magnesium; Phenyl Magnesium Bromide 100-58-3 C6H5BrMg 详情 详情
(I) 22391 4,4-bis(4-hydroxyphenyl)pentanoic acid 126-00-1 C17H18O4 详情 详情
(II) 22392 methyl 4,4-bis(4-hydroxyphenyl)pentanoate C18H20O4 详情 详情
(III) 31669 4-[4-hydroxy-1-(4-hydroxyphenyl)-1-methyl-4,4-diphenylbutyl]phenol C29H28O3 详情 详情
(IV) 31670 4-[1-(4-hydroxyphenyl)-1-methyl-4,4-diphenylbutyl]phenol C29H28O2 详情 详情
(V) 18672 azepane 111-49-9 C6H13N 详情 详情

合成路线3

该中间体在本合成路线中的序号:(XVII)

The reaction of 4-hydroxybenzyl alcohol (V) with ethyl 2-bromoacetate (XI) by means of K2CO3 gives the phenoxyacetate (XII), which is then treated with SOCl2 in THF to obtain the benzyl chloride (XIII). Reaction of (XIII) with the indole derivative (VII) by means of NaH in DMF yields the adduct (XIV), whose ester group is reduced with LiAlH4 in THF to afford the 2-hydroxyethoxy compound (XV). Treatment of (XV) with CBr4 and PPh3 in THF provides the 2-bromoethoxy compound (XVI), which is converted into compound (XVIIII) by reaction with hexamethyleneimine (homopiperidine) (XVII) in THF. Finally, compound (XVIII) is debenzylated by hydrogenation with either H2 over Pd/C in ethanol/THF or with cyclohexadiene and Pd/C in THF/EtOH.

1 Miller, C.P.; Collini, M.D.; Tran, B.D.; et al.; Design, synthesis, and preclinical characterization of novel, highly selective indole estrogens. J Med Chem 2001, 44, 11, 1654.
2 Harris, H.A.; Miller, C.P.; Komm, B.S.; Bazedoxifene Acetate. Drugs Fut 2002, 27, 2, 117.
3 Miller, C.P.; Tran, B.D.; Collini, M.D. (American Home Products Corp.); Estrogenic agents. EP 0802183; JP 1998036346; US 5998402 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(V) 29474 4-(hydroxymethyl)phenol; 4-hydroxyphenylmethanol 4-hydroxybenzenemethanol; 4-Hydroxybenzyl alcohol 623-05-2 C7H8O2 详情 详情
(VII) 38490 5-(benzyloxy)-2-[4-(benzyloxy)phenyl]-3-methyl-1H-indole; benzyl 4-[5-(benzyloxy)-3-methyl-1H-indol-2-yl]phenyl ether C29H25NO2 详情 详情
(XI) 16640 Ethyl 2-bromoacetate; Ethyl bromoacetate 105-36-2 C4H7BrO2 详情 详情
(XII) 51988 ethyl 2-[4-(hydroxymethyl)phenoxy]acetate C11H14O4 详情 详情
(XIII) 38491 ethyl 2-[4-(chloromethyl)phenoxy]acetate C11H13ClO3 详情 详情
(XIV) 38492 ethyl 2-[4-([5-(benzyloxy)-2-[4-(benzyloxy)phenyl]-3-methyl-1H-indol-1-yl]methyl)phenoxy]acetate C40H37NO5 详情 详情
(XV) 38493 2-[4-([5-(benzyloxy)-2-[4-(benzyloxy)phenyl]-3-methyl-1H-indol-1-yl]methyl)phenoxy]-1-ethanol C38H35NO4 详情 详情
(XVI) 38494 benzyl 4-[5-(benzyloxy)-1-[4-(2-bromoethoxy)benzyl]-3-methyl-1H-indol-2-yl]phenyl ether; 5-(benzyloxy)-2-[4-(benzyloxy)phenyl]-1-[4-(2-bromoethoxy)benzyl]-3-methyl-1H-indole C38H34BrNO3 详情 详情
(XVII) 18672 azepane 111-49-9 C6H13N 详情 详情
(XVIII) 38495 1-[4-[2-(1-azepanyl)ethoxy]benzyl]-5-(benzyloxy)-2-[4-(benzyloxy)phenyl]-3-methyl-1H-indole; 4-[1-[4-[2-(1-azepanyl)ethoxy]benzyl]-5-(benzyloxy)-3-methyl-1H-indol-2-yl]phenyl benzyl ether C44H46N2O3 详情 详情

合成路线4

该中间体在本合成路线中的序号:(I)

By condensation of N-(perhydroazepin-1-ylcarbonyl)-L-leucine (V) with 4-O-benzyl-L-tyrosine tert-butyl ester (VIII) by means of HOBT and diisopropylethylamine in DMF. The two peptide intermediates (V) and (VIII) have been obtaines a follows: L-Leucine fragment (V): The carbonatation of perhydroazepine (I) with CO2 and pyridine followed by reaction with SOCl2 gives perhydroazepin-1-ylcarbonyl chloride (II), which is condensed with L-leucine benzyl ester (III) yielding the N-acylated leucine ester (IV). Finally, this compound is debenzylated by hydrogenation with H2 over Pd/C in THF to afford the target intermediate (V). Tyrosine fragment (VIII): By esterification of 4-O-benzyl-L-tyrosine (VI) with isobutylene (VII) by means of sulfuric acid in dioxane.

1 Malone, T.; et al.; Identification and SAR studies of PD 151307, a novel N-type calcium channel blocker. 217th ACS Natl Meet (March 21 1999, Anaheim) 1999, Abst MEDI 122.
2 Roth, B.D.; Connor, D.T.; Malone, T.C.; Hamilton, H.W.; Rafferty, M.F.; Hu, L.-Y.; Cody, W.L.; He, J.X.; Nadasdi, L.; Brogley, L.; Urge, L.; Silva, D.F.; Song, Y.; Szoke, B.G.; Booth, R.J.; Lescosky, J. (Neurex Corp.; Pfizer Inc.); Peptidyl calcium channel blockers. US 6423689 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18672 azepane 111-49-9 C6H13N 详情 详情
(II) 26713 1-azepanecarbonyl chloride C7H12ClNO 详情 详情
(III) 22252 Benzyl (2S)-2-amino-4-methylpentanoate; Benzyl (S)-leucinate C13H19NO2 详情 详情
(IV) 26714 benzyl (2S)-2-[(1-azepanylcarbonyl)amino]-4-methylpentanoate C20H30N2O3 详情 详情
(V) 26715 (2S)-2-[(1-azepanylcarbonyl)amino]-4-methylpentanoic acid C13H24N2O3 详情 详情
(VI) 26716 (2S)-2-amino-3-[4-(benzyloxy)phenyl]propionic acid 16652-64-5 C16H17NO3 详情 详情
(VII) 15926 2-methyl-1-propene; isobutylene 115-11-7 C4H8 详情 详情
(VIII) 26717 tert-butyl (2S)-2-amino-3-[4-(benzyloxy)phenyl]propanoate C20H25NO3 详情 详情

合成路线5

该中间体在本合成路线中的序号:(I)

Hexahydroazepine (I) was coupled with N-Boc-glycine (II) by means of EDC and HOBt, and the resulting amide (III) was reduced with LiAlH4 to give diamine (IV). Subsequent coupling of (IV) with 3,4-dichlorophenylacetic acid (V) in the presence of DCC afforded amide (VI). Finally, reduction of (VI) with aluminum hydride in THF provided the title compound.

1 de Costa, B.R.; et al.; Synthesis, characterization, and biological evaluation of a novel class of N-(arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamines: Structural requirements and binding affinity at the sigma receptor. J Med Chem 1992, 35, 1, 38.
2 De Costa, B.R.; Radesca, L.; Bowen, W.; Long, J.; Walker, J.M.; Rice, K.C.; Gray, N.M.; Contreras, P.C. (Pharmacia Corp.); N-(Arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamine derivs. for CNS disorders. EP 0518216; WO 9222279 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18672 azepane 111-49-9 C6H13N 详情 详情
(II) 18066 N-alpha-t-BOC-glycine; 2-[(tert-butoxycarbonyl)amino]acetic acid 4530-20-5 C7H13NO4 详情 详情
(III) 30416 tert-butyl 2-(1-azepanyl)-2-oxoethylcarbamate C13H24N2O3 详情 详情
(IV) 30417 N-[2-(1-azepanyl)ethyl]-N-methylamine; 2-(1-azepanyl)-N-methyl-1-ethanamine C9H20N2 详情 详情
(V) 30414 2-(3,4-dichlorophenyl)acetic acid;2-(3,4-Dichlorophenyl)acetic acid 5807-30-7 C8H6Cl2O2 详情 详情
(VI) 30418 N-[2-(1-azepanyl)ethyl]-2-(3,4-dichlorophenyl)-N-methylacetamide C17H24Cl2N2O 详情 详情

合成路线6

该中间体在本合成路线中的序号:(VII)

The reaction of 2-chloro-5-nitroaniline (I) with NaNO2 in HCl and HOAc, followed by addition of CuCl2 and SO2 yields sulfonyl chloride (II). Reaction of (II) with NH4OH affords sulfonamide (III), which is then treated 3-methylaniline (IV) in 3-chlorotoluene to furnish intermediate (V). Final conversion of (V) into the target product is achieved by treatment in H2O/acetone with NaOH and carbamimidothioate (VIII), which can be obtained by reaction of dimethyl N-cyanodithioiminocarbonate (VI) with amine (VII) in EtOH.

1 Delarge, J.; Masereel, B.; Dogne, J.-M. (University of Liege); Benzenic sulphonamide derivs. and their uses. WO 0042004 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 43033 2-chloro-5-nitroaniline; 2-chloro-5-nitrophenylamine 6283-25-6 C6H5ClN2O2 详情 详情
(II) 43034 2-chloro-5-nitrobenzenesulfonyl chloride;2-Chloro-5-nitro-benzenesulfonyl chloride;2-Chloro-5-nitrophenylsulfonyl chloride;6-Chloro-3-nitrobenzenesulfonyl chloride 4533-95-3 C6H3Cl2NO4S 详情 详情
(III) 43035 2-chloro-5-nitrobenzenesulfonamide 96-72-0 C6H5ClN2O4S 详情 详情
(IV) 30687 3-methylphenylamine; m-toluidine 108-44-1 C7H9N 详情 详情
(V) 43036 5-nitro-2-(3-toluidino)benzenesulfonamide C13H13N3O4S 详情 详情
(VI) 43037 [[bis(methylsulfanyl)methylene]amino]methane C4H9NS2 详情 详情
(VII) 18672 azepane 111-49-9 C6H13N 详情 详情
(VIII) 43038 methyl N-cyano-1-azepanecarbimidothioate C9H15N3S 详情 详情

合成路线7

该中间体在本合成路线中的序号:(VI)

The alkylation of 6-chloro-2-fluoropurine (I) with isopropanol (II) under Mitsunobu conditions gives 6-chloro-2-fluoro-9-isopropylpurine (III), which is regioselectively alkylated at the 6 position with 4-methoxybenzylamine (IV) to yield 2-fluoro-9-isopropyl-N6-(4-methoxybenzyl)adenine (V). Finally, the 2-fluoro position of (V) is aminated with perhydroazepine (VI) in n-butanol at high temperature in a sealed tube to afford the target trisubstituted purine.

1 Verdugo, D.E.; et al.; Discovery of estrogen sulfotransferase inhibitors from a purine library screen. J Med Chem 2001, 44, 17, 2683.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 51672 6-chloro-2-fluoro-9H-purine C5H2ClFN4 详情 详情
(II) 19250 2-propanol 67-63-0 C3H8O 详情 详情
(III) 51673 6-chloro-2-fluoro-9-isopropyl-9H-purine C8H8ClFN4 详情 详情
(IV) 15098 4-Methoxybenzylamine; (4-Methoxyphenyl)methanamine 2393-23-9 C8H11NO 详情 详情
(V) 51674 N-(2-fluoro-9-isopropyl-9H-purin-6-yl)-N-(4-methoxybenzyl)amine; 2-fluoro-9-isopropyl-N-(4-methoxybenzyl)-9H-purin-6-amine C16H18FN5O 详情 详情
(VI) 18672 azepane 111-49-9 C6H13N 详情 详情

合成路线8

该中间体在本合成路线中的序号:(II)

The cuprous chloride-catalyzed Mannich reaction between propargyl alcohol (I), hexahydroazepine (II) and formaldehyde furnished aminobutynol (III), which was further converted to the corresponding chloride (IV) upon treatment with SOCl2. The title compound was then synthesized by alkylation of the anion of 9-benzylfluorene (V) with chloride (IV) in DMSO.

1 Roxburgh, C.J.; et al.; Synthesis and structure-activity relationships of cetiedil analogues as blockers of the Ca2+-activated K+ permeability of erythrocytes. J Med Chem 2001, 44, 20, 3244.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 16664 Propargyl Alcohol; 2-propyn-1-ol 107-19-7 C3H4O 详情 详情
(II) 18672 azepane 111-49-9 C6H13N 详情 详情
(III) 51109 4-(1-azepanyl)-2-butyn-1-ol C10H17NO 详情 详情
(IV) 51110 1-(4-chloro-2-butynyl)azepane C10H16ClN 详情 详情
(V) 51111 9-Benzylfluorene 1572-46-9 C20H16 详情 详情

合成路线9

该中间体在本合成路线中的序号:(IV)

The reaction of 1,3-benzodioxol-5-ylmethylamine (I) with acryloyl chloride (II) by means of TEA gives the acrylamide (III), which is reductocondensed with perhydroazepine (IV) by means of LiAlH4 or BH3/THF in THF to yield the secondary amine (V). Finally this compound is condensed with 5-chloro-3-(3,5-difluorophenyl)isoxazole (VI) by means of BuLi in diethyl ether to afford the target tertiary amine. The intermediate 5-chloro-3-(3,5-difluorophenyl)isoxazole (VI) has been obtained by two related ways: The condensation of 3.5-difluorobenzoyl chloride (VII) with malonic acid monoethyl ester (VIII) by means of BuLi gives 2-(3,5-difluorobenzoyl)acetic acid ethyl ester (IX), which is cyclized with hydroxylamine in HOAc to yield 3-(3,5-difluorophenyl)isoxazol-5-ol (X). Finally this compound is treated with POCl3 to afford the desired 5-chloro-3-(3,5-difluorophenyl)isoxazole (VI) intermediate. Alternatively, the reaction of 3,5-difluoroacetophenone (XI) with diethyl carbonate (XII) by means of NaH yields also the already reported intermediate 2-(3,5-difluorobenzoyl)acetic acid ethyl ester (IX)

1 Nantermet, P.G.; et al.; Discovery of a nonpeptide small molecule antagonist of the human platelet thrombin receptor (PAR-1). Bioorg Med Chem Lett 2002, 12, 3, 319.
2 Freidinger, R.M.; Selnick, H.G.; Connolly, T.; Barrow, J.C.; Nantermet, P.G. (Merck & Co., Inc.); Isoxazole thrombin receptor antagonists. GB 2356198 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 33669 1,3-benzodioxol-5-ylmethylamine; 1,3-benzodioxol-5-ylmethanamine; 3,4-Methylendioxybenzylamine 2620-50-0 C8H9NO2 详情 详情
(II) 11577 Acryloyl chloride; Acrylyl chloride;2-Propenoyl chloride 814-68-6 C3H3ClO 详情 详情
(III) 56910 N-(1,3-benzodioxol-5-ylmethyl)acrylamide C11H11NO3 详情 详情
(IV) 18672 azepane 111-49-9 C6H13N 详情 详情
(V) 56911 3-(1-azepanyl)-N-(1,3-benzodioxol-5-ylmethyl)-1-propanamine; N-[3-(1-azepanyl)propyl]-N-(1,3-benzodioxol-5-ylmethyl)amine C17H26N2O2 详情 详情
(VI) 56912 5-chloro-3-(3,5-difluorophenyl)isoxazole C9H4ClF2NO 详情 详情
(VII) 56913 3,5-Difluorobenzoyl chloride 129714-97-2 C7H3ClF2O 详情 详情
(VIII) 15086 3-ethoxy-3-oxopropionic acid 1071-46-1 C5H8O4 详情 详情
(IX) 56914 ethyl 3-(3,5-difluorophenyl)-3-oxopropanoate C11H10F2O3 详情 详情
(X) 56915 3-(3,5-difluorophenyl)-5-isoxazolol C9H5F2NO2 详情 详情
(XI) 56916 3,5-Difluoroacetophenone 123577-99-1 C8H6F2O 详情 详情
(XII) 17470 diethyl carbonate; diethylcarbonate 105-58-8 C5H10O3 详情 详情

合成路线10

该中间体在本合成路线中的序号:(I)

 

1 Abe T. Pandey SK, Baba H. 2000. Electrochemical fluorination of hexahydroazepine, methylpiperidines and methyl l-hexahydroazepine-acetate: the preparation of F-(l-hexahydroazepine-acetyl fluoride) and its derivatives. J Fluor Chem, 105(1):149--157
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18672 azepane 111-49-9 C6H13N 详情 详情
Extended Information